SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-119743
Filing Date
2023-11-20
Accepted
2023-11-20 08:25:41
Documents
16
Period of Report
2023-11-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2330992d1_8k.htm   iXBRL 8-K 35348
2 EXHIBIT 10.1 tm2330992d1_ex10-1.htm EX-10.1 202577
3 EXHIBIT 99.1 tm2330992d1_ex99-1.htm EX-99.1 14328
7 GRAPHIC tm2330992d1_ex10-1img001.jpg GRAPHIC 9196
8 GRAPHIC tm2330992d1_ex99-1img001.jpg GRAPHIC 10406
  Complete submission text file 0001104659-23-119743.txt   499613

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA enfn-20231120.xsd EX-101.SCH 3015
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE enfn-20231120_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enfn-20231120_pre.xml EX-101.PRE 22359
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2330992d1_8k_htm.xml XML 3430
Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Filer) CIK: 0001868912 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40949 | Film No.: 231420797
SIC: 7372 Services-Prepackaged Software